The chemotherapy-induced myelosuppression treatments market is expected to increase from its present size of US$ 8.06 billion in 2022 to US$ 9.78 billion by 2028, with a cumulative annual growth rate (CAGR) of 3.3%. A new study by FMI reveals that the chemotherapy-induced myelosuppression treatment market is expected to grow at a subdued 3% y-o-y …